Effect of the adenosine A2A-receptors on the brain stability with respect to complete global cerebral ischemia

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 63, Issue 6, 2000, Pages 11-

  Kulinskii, V I ^a   Minakina, L N ^a   Usov, L A ^a  

^a IRKUTSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042686793     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. S. Alexander, A. Mead, and J. Peters, Trends Pharmacol. Sci., 33, TiPS Receptor and Ion Channel Nomenclature Suppl., 7-8 (1998).
2. E. Bona, U. Aden, E. Gilland, et al., Neuropharmacology, 36(9), 1327-38 (1997).
3. M. R. Domenici, A. S. de Carolis, and S. Sagratella, Brit. J. Pharmacol., 118(6), 1551-7 (1996).
4. B. B. Fredholm, Neuroprotective Agents and Cerebral Ischaemia, A. R. Green, A. J. Cross (eds), Int. Rev. Neurobiol., 40, 259-280 (1997).
5. A. Fucunaga, G. Alexander, and H. Mamiya, Drug Development Res., 43(1), 75 (1998).
6. V. I. Kulinsky, G. Z. Sufianova, and L. N. Minakina, L. A. Usov, Drug Development Res., 43(1), 46 (1998).
7. S. Latini, F. Bordoni, R. Corrandetti, et al., Drug Development Res., 43(1), 56 (1998).
8. A. Monopoli, G. Lozza, A. Forlani, et al., Drug Development Res., 43(1), 71 (1998).
9. E. Ongini, and B. B. Fredholm, Trends Pharmacol. Sci., 17(10), 364-372 (1996).
10. J. W. Phillis, Brain Res., 705(1), 79-84 (1995).
11. S. M. Poucher, J. R. Keddie, P. Singh, et al., Brit. J. Pharmacol., 115, 1096-1102 (1995).
12. M. I. Sweeney, Neurosci. Biobehav. Revs., 21(2), 207-217 (1997).
13. D. K. J. E. Von Lubitz, R. C. S. Lin, and K. A. Jacobson, Europ. J. Pharmacol., 287(2), 207-217 (1995).